about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

Faculty directory

Back to alphabetical index


Alliric I. Willis, MD alliric l. willis, md


Associate Professor, Surgery

Associate Professor, Fels Institute for

Cancer Research and Molecular Biology

Telephone:  215-707-2072

Fax:  215-707-1915

Email: alliric.willis@tuhs.temple.edu


Department of Surgery, Division of Surgical Oncology

Fels Institute for Cancer Research

and Molecular Biology


Educational Background:


AB, History and Science, Harvard College, Cambridge, MA, 1992


MD, University of Pennsylvania School of Medicine, Philadelphia, PA, 1996


Surgical Research Fellowship, Molecular Biology, Yale University, New Haven, CT, 2000


Residency, General Surgery, Washington University in St. Louis, Barnes-Jewish Hospital, St. Louis, MO, 2004


Fellowship, Surgical Oncology , Fox Chase Cancer Center, Philadelphia, PA, 2006


Return to top



clinical and research Interests:

  • Thyroid and parathyroid surgery, including minimally invasive techniques
  • Breast cancer with special interest in breast conserving treatment and sentinel lymph node biopsy
  • Sarcoma, soft tissue and skin tumors
  • Gastric and intestinal cancer
  • Quality and disparities in cancer treatment and outcomes

Return to top



board certifications:


  • General Surgery


Return to top





  • Society of Surgical Oncology
  • American Society of Clinical Oncology
  • Association of Academic Surgeons


Return to top




Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

26282892. Powers BD, Montes JA, Nguyen DC, Nick DA, Daly MP, Davey A, Willis AI, Demographic risk factors impacting timely radiation therapy completion after breast conserving surgery. Am J Surg 210:5(891-5)2015 Nov

26048632. Davey MP, Bilkins B, Diamond G, Willis AI, Mitchell EP, Davey A, Young FM, African American Patients' Psychosocial Support Needs and Barriers to Treatment: Patient Needs Assessment. J Cancer Educ :()2015 Jun 7

23862192. Willis AI, Taghavi S, Jayarajan SN, Davey A, Reply to G. Piessen et al. J Clin Oncol 31:16(2060-1)2013 Jun 1

23838863. Taghavi S, Jayarajan SN, Powers BD, Davey A, Willis AI, Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis. Dis Colon Rectum 56:8(952-9)2013 Aug

23334252. Nitzkorski JR, Willis AI, Nick D, Zhu F, Farma JM, Sigurdson ER, Association of race and socioeconomic status and outcomes of patients with rectal cancer. Ann Surg Oncol 20:4(1142-7)2013 Apr

22927530. Taghavi S, Jayarajan SN, Davey A, Willis AI, Prognostic significance of signet ring gastric cancer. J Clin Oncol 30:28(3493-8)2012 Oct 1

22828144. Taghavi S, Jayarajan SN, Duran JM, Gaughan JP, Pathak A, Santora TA, Willis AI, Goldberg AJ, Does payer status matter in predicting penetrating trauma outcomes? Surgery 152:2(227-31)2012 Aug

21193465. Willis AI, Sadowitz B, Fuse S, Maier KG, Lee TS, Wang XJ, Tuszynski GP, Sumpio BE, Gahtan V, Thrombospondin 1, fibronectin, and vitronectin are differentially dependent upon RAS, ERK1/2, and p38 for induction of vascular smooth muscle cell chemotaxis. Vasc Endovascular Surg 45:1(55-62)2011 Jan

18319354. Wang XJ, Maier K, Fuse S, Willis AI, Olson E, Nesselroth S, Sumpio BE, Gahtan V, Thrombospondin-1-induced migration is functionally dependent upon focal adhesion kinase. Vasc Endovascular Surg 42:3(256-62)2008 Jun-Jul

17525953. Willis AI, Ridge JA, Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck 29:11(979-85)2007 Nov

14760473. Willis AI, Pierre-Paul D, Sumpio BE, Gahtan V, Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg 38:1(11-23)2004 Jan-Feb

11409850. Smith JD, Davies N, Willis AI, Sumpio BE, Zilla P, Cyclic stretch induces the expression of vascular endothelial growth factor in vascular smooth muscle cells. Endothelium 8:1(41-8)2001

11241132. Nesselroth SM, Willis AI, Fuse S, Olson ET, Lawler J, Sumpio BE, Gahtan V, The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis. J Vasc Surg 33:3(595-600)2001 Mar

10842153. Willis AI, Fuse S, Wang XJ, Chen E, Tuszynski GP, Sumpio BE, Gahtan V, Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis. J Vasc Surg 31:6(1160-7)2000 Jun

10455885. Gahtan V, Wang XJ, Willis AI, Tuszynski GP, Sumpio BE, Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent. Surgery 126:2(203-7)1999 Aug

10359937. Gahtan V, Wang XJ, Ikeda M, Willis AI, Tuszynski GP, Sumpio BE, Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells. J Vasc Surg 29:6(1031-6)1999 Jun

Return to top